相似文献
1
Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.
J Bacteriol. 1963 Jan;85(1):230-6. doi: 10.1128/jb.85.1.230-236.1963.
2
Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.
J Bacteriol. 1962 Mar;83(3):515-22. doi: 10.1128/jb.83.3.515-522.1962.
3
Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.
Appl Microbiol. 1963 Jul;11(4):330-4. doi: 10.1128/am.11.4.330-334.1963.
4
Studies on immunity in anthrax. XI. Control of cellular permeability by bicarbonate ion in relation to protective antigen elaboration.
J Bacteriol. 1963 Jan;85(1):237-43. doi: 10.1128/jb.85.1.237-243.1963.
5
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.
6
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
Infect Immun. 1990 Feb;58(2):303-8. doi: 10.1128/iai.58.2.303-308.1990.
7
Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
FEMS Immunol Med Microbiol. 2009 Nov;57(2):165-72. doi: 10.1111/j.1574-695X.2009.00595.x. Epub 2009 Aug 6.
8
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
PLoS One. 2015 Jul 24;10(7):e0130952. doi: 10.1371/journal.pone.0130952. eCollection 2015.
9
Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
Infect Immun. 1992 Feb;60(2):662-8. doi: 10.1128/iai.60.2.662-668.1992.
10
Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
Vaccine. 2008 Oct 29;26(46):5814-21. doi: 10.1016/j.vaccine.2008.08.031. Epub 2008 Sep 9.
引用本文的文献
1
A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.
Biomedicines. 2022 Aug 22;10(8):2050. doi: 10.3390/biomedicines10082050.
2
Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity.
Clin Vaccine Immunol. 2014 Feb;21(2):156-64. doi: 10.1128/CVI.00560-13. Epub 2013 Dec 4.
3
Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
Vaccine. 2013 Apr 3;31(14):1856-63. doi: 10.1016/j.vaccine.2013.01.040. Epub 2013 Feb 13.
4
A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.
Protein Expr Purif. 2011 Nov;80(1):80-90. doi: 10.1016/j.pep.2011.05.016. Epub 2011 Aug 7.
5
Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.
Neurochem Res. 2011 Jun;36(6):927-38. doi: 10.1007/s11064-011-0427-0. Epub 2011 Feb 25.
6
Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.
Mol Ther. 2009 Feb;17(2):373-9. doi: 10.1038/mt.2008.242. Epub 2008 Nov 11.
7
Genetic medicine strategies to protect against bioterrorism.
Trans Am Clin Climatol Assoc. 2006;117:297-310; discussion 310-1.
8
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
Infect Immun. 2005 Oct;73(10):6885-91. doi: 10.1128/IAI.73.10.6885-6891.2005.
9
Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Infect Immun. 2005 Sep;73(9):5978-87. doi: 10.1128/IAI.73.9.5978-5987.2005.
10
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.
J Immune Based Ther Vaccines. 2004 May 12;2(1):5. doi: 10.1186/1476-8518-2-5.
本文引用的文献
1
Field Evaluation of a Human Anthrax Vaccine.
Am J Public Health Nations Health. 1962 Apr;52(4):632-45. doi: 10.2105/ajph.52.4.632.
2
The serological relationship between purified preparations of factors I and II of the anthrax toxin produced in vivo and in vitro.
J Gen Microbiol. 1960 Feb;22:219-28. doi: 10.1099/00221287-22-1-219.
3
Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.
J Bacteriol. 1962 Mar;83(3):515-22. doi: 10.1128/jb.83.3.515-522.1962.
4
Purification of factor I and recognition of a third factor of the anthrax toxin.
J Gen Microbiol. 1961 Sep;26:49-63. doi: 10.1099/00221287-26-1-49.
5
Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis.
J Bacteriol. 1962 Jun;83(6):1274-80. doi: 10.1128/jb.83.6.1274-1280.1962.
6
7
Production of toxin in vitro by Bacillus anthracis and its spearation into two components.
J Bacteriol. 1960 Mar;79(3):450-5. doi: 10.1128/jb.79.3.450-455.1960.
8
Studies on immunity in anthrax. VII. Carbohydrate metabolism of Bacillus anthracis in relation to elaboration of protective antigen.
J Bacteriol. 1959 Jul;78(1):137-45. doi: 10.1128/jb.78.1.137-145.1959.
9
Further purification studies on the protective antigen of Bacillus anthracis produced in vitro.
J Bacteriol. 1958 Aug;76(2):192-202. doi: 10.1128/jb.76.2.192-202.1958.
10
An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production.
J Gen Microbiol. 1957 Oct;17(2):505-16. doi: 10.1099/00221287-17-2-505.
Zotero 插件